Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

Overview of attention for article published in Cancer Immunology Research, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs

twitter: 54 X users
patent: 1 patent

Citations

dimensions_citation: 85 Dimensions

Readers on

mendeley: 100 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 82 X posts from 54 X users, with an upper bound of 369,556 followers.

RT @Lucky13McCoy: Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting…

03 Sep 2024

Reply Repost Favourite

RT @CIR_AACR: Read the article by the recipients of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenbe…

19 Jun 2024

Reply Repost Favourite

RT @CIR_AACR: Read the article by the recipients of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenbe…

18 Jun 2024

Reply Repost Favourite

Read the article by the recipients of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenberg et al.— T-cell Therapy Targeting p53 Neoantigens in Solid Tumors. https://t.co/dlP78ldxPq

18 Jun 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 78 additional X posts.